<article xmlns="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle http://dtd.nlm.nih.gov/2.0/xsd/archivearticle.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Phytomedicine</journal-id>
      <journal-title-group>
        <journal-title>Phytomedicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0944-7113</issn>
      <issn pub-type="epub">1618-095X</issn>
      <publisher>
        <publisher-name>Urban &amp; Fischer Verlag</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">3111854</article-id>
      <article-id pub-id-type="pmid">20851587</article-id>
      <article-id pub-id-type="publisher-id">PHYMED50921</article-id>
      <article-id pub-id-type="doi">10.1016/j.phymed.2010.08.002</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Predicting cyclooxygenase inhibition by three-dimensional pharmacophoric profiling. Part II: Identification of enzyme inhibitors from Prasaplai, a Thai traditional medicine</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Waltenberger</surname>
            <given-names>Birgit</given-names>
          </name>
          <xref rid="aff0005" ref-type="aff">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Schuster</surname>
            <given-names>Daniela</given-names>
          </name>
          <xref rid="aff0010" ref-type="aff">b</xref>
          <xref rid="aff0015" ref-type="aff">c</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Paramapojn</surname>
            <given-names>Sompol</given-names>
          </name>
          <xref rid="aff0020" ref-type="aff">d</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gritsanapan</surname>
            <given-names>Wandee</given-names>
          </name>
          <xref rid="aff0020" ref-type="aff">d</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wolber</surname>
            <given-names>Gerhard</given-names>
          </name>
          <xref rid="aff0010" ref-type="aff">b</xref>
          <xref rid="aff0015" ref-type="aff">c</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rollinger</surname>
            <given-names>Judith M.</given-names>
          </name>
          <xref rid="aff0005" ref-type="aff">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Stuppner</surname>
            <given-names>Hermann</given-names>
          </name>
          <email>Hermann.Stuppner@uibk.ac.at</email>
          <xref rid="aff0005" ref-type="aff">a</xref>
          <xref rid="cor0005" ref-type="corresp">⁎</xref>
        </contrib>
      </contrib-group>
      <aff id="aff0005"><label>a</label>Institute of Pharmacy, Pharmacognosy, University of Innsbruck, 6020 Innsbruck, Austria</aff>
      <aff id="aff0010"><label>b</label>Institute of Pharmacy, Pharmaceutical Chemistry, University of Innsbruck, 6020 Innsbruck, Austria</aff>
      <aff id="aff0015"><label>c</label>Inte:Ligand GmbH, 1070 Vienna, Austria</aff>
      <aff id="aff0020"><label>d</label>Department of Pharmacognosy, Faculty of Pharmacy, Mahidol University, Bangkok 10400, Thailand</aff>
      <author-notes>
        <corresp id="cor0005"><label>⁎</label>Corresponding author. Tel.: +43 512 507 5300; fax: +43 512 507 2939. <email>Hermann.Stuppner@uibk.ac.at</email></corresp>
      </author-notes>
      <pub-date pub-type="pmc-release">
        <day>15</day>
        <month>1</month>
        <year>2011</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="ppub"/>. -->
      <pub-date pub-type="ppub">
        <day>15</day>
        <month>1</month>
        <year>2011</year>
      </pub-date>
      <volume>18</volume>
      <issue>2-3</issue>
      <fpage>119</fpage>
      <lpage>133</lpage>
      <permissions>
        <copyright-statement>© 2011 Elsevier GmbH.</copyright-statement>
        <copyright-year>2010</copyright-year>
        <copyright-holder>Elsevier GmbH</copyright-holder>
        <license>
          <license-p>This document may be redistributed and reused, subject to <ext-link ext-link-type="uri" xlink:href="http://www.elsevier.com/wps/find/authorsview.authors/supplementalterms1.0">certain conditions</ext-link>.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Prasaplai is a medicinal plant mixture that is used in Thailand to treat primary dysmenorrhea, which is characterized by painful uterine contractility caused by a significant increase of prostaglandin release. Cyclooxygenase (COX) represents a key enzyme in the formation of prostaglandins. Former studies revealed that extracts of Prasaplai inhibit COX-1 and COX-2. In this study, a comprehensive literature survey for known constituents of Prasaplai was performed. A multiconformational 3D database was created comprising 683 molecules. Virtual parallel screening using six validated pharmacophore models for COX inhibitors was performed resulting in a hit list of 166 compounds. 46 Prasaplai components with already determined COX activity were used for the external validation of this set of COX pharmacophore models. 57% of these components were classified correctly by the pharmacophore models. These findings confirm that the virtual approach provides a helpful tool (i) to unravel which molecular compounds might be responsible for the COX-inhibitory activity of Prasaplai and (ii) for the fast identification of novel COX inhibitors.</p>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>Prasaplai</kwd>
        <kwd>Traditional medicine of Thailand</kwd>
        <kwd>Natural products</kwd>
        <kwd>Cyclooxygenase</kwd>
        <kwd>Pharmacophore</kwd>
        <kwd>Virtual screening</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="sec0005">
      <title>Introduction</title>
      <p>Virtual screening techniques are very common and widespread in medicinal chemistry (<xref rid="bib0045 bib0040 bib0110" ref-type="bibr">Ekins et al. 2007b,a; Kirchmair et al. 2008</xref>). The general goal of applying such methods is to filter large compound databases <italic>in silico</italic> in order to focus experimental efforts on those candidates which are most promising for showing the desired pharmacological effect. Today, the pharmacophore concept is one of the most widely established methods for virtual screening (<xref rid="bib0120 bib0125" ref-type="bibr">Langer et al. 2006; Leach et al. 2010</xref>). By definition, a pharmacophore is the ensemble of steric and electronic features that is necessary to ensure the optimal supramolecular interactions with a specific biological target and to trigger or block its biological response (<xref rid="bib0265" ref-type="bibr">Wermuth et al. 1998</xref>). Common pharmacophoric features include hydrogen bond donors and acceptors, hydrophobic interactions, aromatic ring systems, positively or negatively ionizable functions, and data on their location in the three-dimensional (3D) space. Moreover, pharmacophore models can be sterically restricted by “forbidden” areas, so-called exclusion volumes, and shapes, of which the latter are usually derived from highly active ligands. One pharmacophore model usually represents one certain binding mode to a receptor or an enzyme. If a compound fulfils the requirements of a pharmacophore model, it is more likely to show biological activity than compounds that do not fit into the model.</p>
      <p>Originally, pharmacophore-based virtual screening has been developed to find bioactive synthetic compounds. More recently, this approach has also shown to be valuable in the field of natural products for the identification of bioactive constituents (<xref rid="bib0195 bib0205" ref-type="bibr">Rollinger et al. 2006, 2008</xref>). In earlier studies single pharmacophore models were used for the virtual screening of natural product (NP) databases (<xref rid="bib0190 bib0185" ref-type="bibr">Rollinger et al. 2004, 2005</xref>). Technological evolution enabled upscaling of the virtual screening protocols using parallel screening (PS) techniques (<xref rid="bib0180 bib0200" ref-type="bibr">Rollinger 2009; Rollinger et al. 2009</xref>). In pharmacophore-based PS, single compounds or small databases are virtually screened against a series of pharmacophore models, aiming at the prediction of pharmacological activity profiles of these molecules (<xref rid="bib0110 bib0180" ref-type="bibr">Kirchmair et al. 2008; Rollinger 2009</xref>). Herein we present a further application scenario of PS, i.e. the search for structurally diverse natural compounds with a defined molecular mode of action.</p>
      <p>Traditional medicine often uses plant mixtures which contain hundreds of compounds from different biosynthetic origin and different chemical scaffolds. In this study, we selected Prasaplai, a Thai traditional medicine, as a sample for the application of PS because (i) it is a complex mixture of NPs, (ii) it is used in traditional medicine to treat inflammatory processes (<xref rid="bib0130" ref-type="bibr">List of Herbal Medicinal Products A.D. 2006</xref>), and (iii) its anti-inflammatory activity has already been confirmed. The hexane extract (25 μg ml<sup>−1</sup>) inhibited both cyclooxygenase (COX)-1 and COX-2 up to 64.43 and 84.50%, respectively (<xref rid="bib0160" ref-type="bibr">Nualkaew et al. 2005</xref>) suggesting that Prasaplai acts at least partially via the inhibition of COX enzymes.</p>
      <p>Prasaplai is composed of twelve ingredients: ten crude plant drugs (the roots of <italic>Acorus calamus</italic> L., the bulbs of <italic>Allium sativum</italic> L., the pericarps of <italic>Citrus hystrix</italic> DC., the rhizomes of <italic>Curcuma zedoaria</italic> Roscoe, the bulbs of <italic>Eleutherine americana</italic> Merr, the seeds of <italic>Nigella sativa</italic> L., the fruits of <italic>Piper chaba</italic> Hunt, the fruits of <italic>Piper nigrum</italic> L., the rhizomes of <italic>Zingiber cassumunar</italic> Roxb., and the rhizomes of <italic>Zingiber officinale</italic> Roscoe) and two pure compounds (sodium chloride and camphor). The main component of Prasaplai is <italic>Zingiber cassumunar</italic> rhizome; it makes up to 50% (w/w) of the mixture. Camphor makes up to 0.6% (w/w) while the other components are equal in weight. Prasaplai is widely used by Thai traditional doctors for relieving primary dysmenorrhea and adjusting the cycle of menstruation (<xref rid="bib0130 bib0155" ref-type="bibr">List of Herbal Medicinal Products A.D. 2006; Nualkaew et al. 2004</xref>).</p>
      <p>The correlation between gynecological disorders and the release of inflammatory mediators was reviewed recently (<xref rid="bib0085 bib0025" ref-type="bibr">Hayes and Rock 2002; Connolly 2003</xref>). Primary dysmenorrhea is characterized by painful uterine contractility caused by a significant increase of prostaglandin release compared with normal menstruation. Since COX-1 and COX-2 represent key enzymes in the formation of prostaglandins, inhibitors of COX are effective therapeutics and the treatment of first choice.</p>
      <p>COX-1 and COX-2 are ideal model targets for a case study since X-ray crystal structures with bound inhibitors, a large number of known active ligands, and datasets for theoretical model validation are available. In our study, a set of five structure-based models and one ligand-based pharmacophore model for COX inhibitors were applied to the constituents of Prasaplai in order to (i) unravel which compounds of Prasaplai might be responsible for the COX-inhibitory activity and (ii) to validate our pharmacophore models using published knowledge about constituents of this herbal remedy.</p>
    </sec>
    <sec sec-type="materials|methods" id="sec0010">
      <title>Materials and methods</title>
      <sec id="sec0015">
        <title>General experimental procedures</title>
        <p>Molecular modeling studies were performed on an Intel Pentium Core 2 Duo 6400 equipped with 1 GB RAM running Linux Fedora Core 6. PS calculations were carried out on an Intel Centrino Core 2 Duo T7500 with 2 GB RAM running Windows XP. For pharmacophore model generation and validation and PS experiments the software programs LigandScout 1.03 (Inte:Ligand GmbH, Vienna, Austria, 2006), Catalyst 4.11 (Accelrys Software Inc., San Diego, USA, 2005), and Discovery Studio 2.1 (Accelrys Software Inc., San Diego, USA, 2007) were used.</p>
      </sec>
      <sec id="sec0020">
        <title>Pharmacophore modeling</title>
        <p>Pharmacophore models may be obtained either via the structure-based or via the ligand-based approach. Structure-based pharmacophore model generation uses 3D structural information on the target protein, which is usually obtained from X-ray crystallography. Protein structures in complex with ligands are publicly available via the Protein Data Bank (PDB) (<xref rid="bib0015" ref-type="bibr">Berman et al. 2003</xref>). Possible chemical interactions between the ligand(s) and the macromolecule are analyzed, and pharmacophore features are placed where interactions are observed. For the ligand-based approach, only information on known biological activity of ligands is required. An algorithm defines common chemical features of a set of bioactive molecules (<xref rid="bib0220" ref-type="bibr">Schuster and Wolber 2010</xref>). For this study, both approaches were applied. All generated models were theoretically evaluated if they found clinically used COX inhibitors and excluded inactive compounds from the hit list. The best six models were used for further experiments. A more detailed description of the pharmacophore model generation and validation and the PS procedure is provided in part I of this study (<xref rid="bib0215" ref-type="bibr">Schuster et al. 2010</xref>).</p>
      </sec>
      <sec id="sec0025">
        <title>NPs database generation</title>
        <p>An extensive literature survey was performed in order to collect compounds of the different plants contained in the Prasaplai mixture. These compounds were stored as 3D structure models in a database, the so-called Prasaplai database. When stereochemistry was not completely specified, all possible stereoisomers were built and stored. Since it is not clear, which 3D conformations the molecules would adopt in the interaction with the target protein, structures were handled as collections of low-energy 3D conformers.</p>
      </sec>
      <sec id="sec0030">
        <title>Parallel virtual screening</title>
        <p>The structures in the Prasaplai database were virtually screened against the pharmacophore model set. A compound was considered to be a hit only if all functions of at least one pharmacophore model were mapped.</p>
      </sec>
    </sec>
    <sec id="sec0035">
      <title>Results and discussion</title>
      <sec id="sec0040">
        <title>Generation and validation of COX inhibitors pharmacophore models</title>
        <p>Several PDB complexes were used as templates for exhaustive pharmacophore model generation. Suitable validation processes were applied to the models to select diverse ones with high enrichment factors and high restrictivity. This approach led to a final collection of five structure-based pharmacophore models of COX enzymes, which were built based upon atomic coordinates published in PDB entries representing protein/ligand complexes (<xref rid="tbl0005" ref-type="table">Table 1</xref>). Since this structure-based model set was not able to recognize actives of diverse chemical structures, a ligand-based pharmacophore model was developed that was able to identify other scaffolds as well. This model was generated by aligning the bioactive conformations of (S)-flurbiprofen and SC-558 (<xref rid="bib0215" ref-type="bibr">Schuster et al. 2010</xref>).</p>
      </sec>
      <sec id="sec0045">
        <title>Generation and PS of the Prasaplai database</title>
        <p>A comprehensive literature survey for known components of Prasaplai was performed. 3D structures of these compounds were collected resulting in a molecular library containing a total number of 683 NPs. The Prasaplai database was subjected to a PS using the five structure-based and the ligand-based COX pharmacophore models. This process resulted in a virtual hit list containing 166 potential COX inhibitors. <xref rid="fig0005" ref-type="fig">Fig. 1</xref> shows the numbers of known components of the different plant ingredients of Prasaplai and the numbers of virtual hits (VH) retrieved from the PS.</p>
      </sec>
      <sec id="sec0050">
        <title>Compound evaluation procedure</title>
        <p>The obtained VH were critically analyzed according to their COX-inhibitory activity that is already evident from literature. For 25 VH literature data about their COX-inhibitory activity were available (<xref rid="tbl0010" ref-type="table">Table 2</xref>). These compounds are ingredients from five of the ten plants Prasaplai is composed of, i.e. <italic>Acorus calamus</italic>, <italic>Nigella sativa</italic>, <italic>Piper nigrum</italic>, <italic>Zingiber cassumunar</italic> and <italic>Zingiber officinale</italic>. Consequently, the pharmacophore model set was validated using compounds of these five plants. All known constituents (VH as well as non-VH, i.e. structures that were not recognized by any of the six pharmacophore models) of these plants were evaluated on available COX-inhibitory activity. Only those structures were considered for the validation process and are described in detail in this study for which published data about the inhibition of COX enzymes are available. The relevant non-VH are shown in <xref rid="tbl0015" ref-type="table">Table 3</xref>.</p>
        <p>For the validation of the pharmacophore models there was not differentiated between COX-1 and COX-2 inhibition since the pharmacophore models are not selective for one isoform. According to their inhibition values for COX-1 and/or COX-2, the respective compounds were grouped into three categories: compounds with IC<sub>50</sub> values below 25.0 μM, between 25.0 and 150.0 μM, and above 150.0 μM were considered as highly active, moderately active, and inactive, respectively. Highly or moderately active VH as well as inactive non-VH were assumed to be predicted correctly by the pharmacophore model set; inactive VH as well as highly or moderately active non-VH were assumed to be predicted incorrectly (<xref rid="fig0010" ref-type="fig">Fig. 2</xref>). The correctness of the virtual prediction was determined for each of these five plants (<xref rid="tbl0020" ref-type="table">Table 4</xref>). <xref rid="fig0015" ref-type="fig">Fig. 3</xref> shows the general workflow performed in this study.</p>
        <sec id="sec0055">
          <title>
            <italic>Zingiber cassumunar</italic>
          </title>
          <p>Five VH of <italic>Zingiber cassumunar</italic> have already been evaluated on their COX-2 inhibitory activity (<xref rid="tbl0010" ref-type="table">Table 2</xref>). Four compounds showed IC<sub>50</sub> values on COX-2 of 2.71–20.68 μM. Only one compound was inactive. Therefore, 80% of the VH were predicted correctly.</p>
          <p>For five non-VH published data about their ability to inhibit COX were available (<xref rid="tbl0015" ref-type="table">Table 3</xref>). Limonene, (E)-4-(3,4-dimethoxyphenyl)but-3-en-1-ol and vanillin showed to be inactive on COX-1 and/or COX-2. There are many publications available describing the suppressive effect of curcumin on the expression of COX-2 leading to a decreased enzyme activity (<xref rid="bib0245" ref-type="bibr">Surh and Kundu 2007</xref>). However, the information regarding direct inhibition of COX is inconsistent, showing a range of IC<sub>50</sub> from 15.9 to over 100 μM. Based on these data curcumin was considered as moderately active.</p>
          <p>Except for curcumin, all known actives were found by the pharmacophore models. These compounds are even highly active COX inhibitors. The inactives were not recognized, thus predicted correctly, except for one compound, i.e. (E)-4-(3,4-dimethoxyphenyl)but-3-en-1-yl acetate.</p>
        </sec>
        <sec id="sec0060">
          <title>
            <italic>Zingiber officinale</italic>
          </title>
          <p>Six VH of <italic>Zingiber officinale</italic> have already been tested for their COX-inhibitory activity (<xref rid="tbl0010" ref-type="table">Table 2</xref>). [6]-Shogaol, [8]-gingerdiol, [6]-paradol, [8]-gingerol, and [8]-shogaol showed IC<sub>50</sub> values for COX-2 below 25.0 μM. Due to its high inhibitory activity especially on COX-2, α-linolenic acid was also considered to be highly active.</p>
          <p>For six non-VH data on the inhibition of COX-1 and/or COX-2 were found (<xref rid="tbl0015" ref-type="table">Table 3</xref>). According to biological tests, linalool, limonene, β-sitosterol, 6β-hydroxystigmast-4-en-3-one, and 1,8-cineole were classified as inactive. Ascorbic acid proofed to be inactive on COX-1 and active on COX-2. According to a third publication ascorbic acid induces the formation and the release of COX-catalyzed arachidonic acid metabolites via the activation of phospholipase A<sub>2</sub> (<xref rid="bib0280" ref-type="bibr">Steinhour et al., 2008</xref>). Based on these inconsistent literate data ascorbic acid was considered as moderately active.</p>
          <p>Except for ascorbic acid, all known actives of <italic>Zingiber officinale</italic> were predicted correctly (they are even highly active), and all known inactives were not recognized by the pharmacophore models. This rate of 92% correct prediction is notably high.</p>
        </sec>
        <sec id="sec0065">
          <title>
            <italic>Nigella sativa</italic>
          </title>
          <p>For ten VH of <italic>Nigella sativa</italic> data on their ability to inhibit COX were available (<xref rid="tbl0010" ref-type="table">Table 2</xref>). According to their high inhibition described in literature, especially of COX-2, α-linolenic acid and linoleic acid were considered as highly active. Palmitoleic acid, myristic acid, pentadecanoic acid, palmitic acid, stearic acid, and erucic acid showed little or no inhibitory activity on COX-1 and COX-2 and thus were considered as inactive. The available literature data for oleic acid were inconsistent. Therefore, it was considered as moderately active. Eugenol has been tested to be moderately active on COX-2.</p>
          <p>The two highly active VH α-linolenic acid and linoleic acid belong to the class of oligo-unsaturated fatty acids. Although this substance class was not part of either model generation molecules or model refinement data sets, it was correctly identified by the pharmacophore models. This proofs that the model set can successfully perform the task of scaffold hopping. The other virtually predicted fatty acids have been determined to be inactive or have only weak inhibitory activity. Obviously, the pharmacophore models could not differentiate between these active and inactive compounds due to their high similarity. Basically, the substance class comprising active compounds was identified.</p>
          <p>For six non-VH literature data about their COX-inhibitory activity were found (<xref rid="tbl0015" ref-type="table">Table 3</xref>). Limonene and linalool have already been discussed above. The IC<sub>50</sub> values of thymoquinone, thymohydroquinone and thymol were determined to be 0.2–2.6 μM for COX-1 and 0.1–1.0 μM for COX-2. Also dithymoquinone showed an IC<sub>50</sub> value for COX-2 of &lt;1.0 μM. Only its IC<sub>50</sub> value for COX-1 was determined to be &gt;100 μM. The fact that these highly active compounds were not recognized by the COX pharmacophore model set may be due to different reasons. Our hypothesis is that the structure-based models recognize mainly fatty acids, and since these hydroquinone derivatives belong to a totally different structure class, they were not found. For the ligand-based pharmacophore model an aromatic ring is mandatory which thymoquinone and dithymoquinone do not comprise. Thymohydroquinone and thymol are too small to fit into the model which results in the missing of one hydrophobic feature when mapping the structures into the pharmacophore model.</p>
        </sec>
        <sec id="sec0070">
          <title>
            <italic>Piper nigrum</italic>
          </title>
          <p>COX inhibition data were found for four VH of <italic>Piper nigrum</italic> (<xref rid="tbl0010" ref-type="table">Table 2</xref>). Eugenol and methyleugenol showed to be moderately active. Nonanoic acid and octanoic acid were considered to be inactive. For nine non-VH, COX-inhibitory data were available in the literature (<xref rid="tbl0015" ref-type="table">Table 3</xref>). Linalool, limonene, safrole, spathulenol, pellitorine, and ledol were described to show no or only weak COX inhibition. Thus they were considered as inactive. Piperine showed to be moderately active. Nonanal and trans-2-nonenal were considered as highly active.</p>
          <p>In summary, three of those nine non-VH showed inhibitory activity on COX enzymes. We suggest that the structure-based pharmacophore models are very selective and thus do not recognize these substance classes. In the case of the ligand-based pharmacophore model piperine misses one hydrophobic feature. The problem of nonanal and trans-2-nonenal is that they do not feature an aromatic ring. If the aromatic ring in the ligand-based pharmacophore model was exchanged by a hydrophobic feature, these two structures were identified as hits. However, without the aromatic ring the model would be very unselective and PS of the Prasaplai database would retrieve a hit list comprising many false positive VH.</p>
        </sec>
        <sec id="sec0075">
          <title>
            <italic>Acorus calamus</italic>
          </title>
          <p>For three VH of <italic>Acorus calamus</italic> literature data about their COX-inhibitory activity were available (<xref rid="tbl0010" ref-type="table">Table 2</xref>). Palmitic acid, α-asarone, and asaraldehyde were considered as inactive due to no or weak inhibition of COX-1 as well as COX-2. Only two non-VH have already been determined on their COX-inhibitory activity: linalool and limonene did not show significant inhibitory activity on COX (<xref rid="tbl0015" ref-type="table">Table 3</xref>).</p>
        </sec>
        <sec id="sec0080">
          <title><italic>Allium sativum</italic>, <italic>Curcuma zedoaria</italic></title>
          <p>58 structures from <italic>Allium sativum</italic> were virtually screened using the pharmacophore model set. This approach resulted in one virtual hit (S-allylmercaptocysteine). Literature survey for COX inhibition data for this substance did not retrieve any information. The virtual screening of the 104 structures from <italic>Curcuma zedoaria</italic> resulted in a hit list comprising five structures. Also for these five compounds no literature data about their COX-inhibitory activity were available. COX-inhibitory effects of plant extracts have been reported (<xref rid="bib0225 bib0010 bib0005 bib0255" ref-type="bibr">Sendl et al. 1992; Ali et al. 1993; Ali 1995; Tohda et al. 2006</xref>). However, since there was no information available about the correctness of the prediction of those VH, compounds of these plants were not used for the validation of the pharmacophore models.</p>
        </sec>
        <sec id="sec0085">
          <title><italic>Citrus hystrix</italic>, <italic>Eleutherine americana</italic>, <italic>Piper chaba</italic></title>
          <p>The PS of the 37 structures from <italic>Citrus hystrix</italic>, the 14 from <italic>Eleutherine americana</italic> and the 18 from <italic>Piper chaba</italic> with the six pharmacophore models resulted in hit lists comprising four, eleven, and twelve structures, respectively. Since literature data on COX inhibition for any of those hits were not available, compounds of these plants were not included in the validation process.</p>
        </sec>
      </sec>
      <sec id="sec0090">
        <title>Camphor, sodium chloride, artefacts</title>
        <p>Camphor and sodium chloride are the two pure compounds in the Prasaplai mixture. Therefore camphor was also added to the molecule library that was virtually screened with the pharmacophore models, as well as the three artefacts that originate during storage of Prasaplai. These fatty acid esters arise from the interaction of compounds of <italic>Nigella sativa</italic> and <italic>Zingiber cassumunar</italic> (<xref rid="bib0155" ref-type="bibr">Nualkaew et al. 2004</xref>). Camphor was not recognized by the pharmacophore models, the three artefacts were found. However, their COX-inhibitory activity has not been determined yet.</p>
      </sec>
      <sec id="sec0095">
        <title>Summary of pharmacophore models validation</title>
        <p>Basically, the compounds with known activity on COX were often predicted correctly by the pharmacophore models (<xref rid="fig0020" ref-type="fig">Fig. 4</xref>, VH; <xref rid="fig0025" ref-type="fig">Fig. 5</xref>, non-VH). In the case of <italic>Acorus calamus</italic>, 40% of the compounds with known activity on COX were predicted correctly, i.e. two inactives out of five compounds with experimentally determined COX-inhibitory activity. For the compounds of <italic>Nigella sativa</italic>, <italic>Piper nigrum</italic>, and <italic>Zingiber cassumunar</italic> with known activity on COX-38, 62, and 80% correct prediction was obtained, respectively. For the compounds of <italic>Zingiber officinale</italic> the highest rate of correct prediction was achieved: eleven out of twelve components, i.e. 92%. Only one active non-VH, ascorbic acid, was not recognized by the pharmacophore model set, thus predicted incorrectly.</p>
        <p>In total, from the 25 VH with known activity on COX, eleven were reported to be highly active, three moderately active, and eleven inactive. This gives a rate of correct prediction of 56%. Further, out of the 21 non-VH already determined for their COX activity, six are highly active, three are moderately active and twelve non-VH are inactive, resulting in 57% of correct prediction. Thus, also the combination of these VH and non-VH provides a total rate of correct prediction of 57%, i.e. 26 out of 46 compounds.</p>
      </sec>
    </sec>
    <sec id="sec0100">
      <title>Discussion</title>
      <p>In general, random screening or high-throughput screening of unbiased sets of compounds results in estimated average hit rates of 0.05–0.2%. With virtual screening techniques average hit rates of 5–25% are commonly gained (<xref rid="bib0165" ref-type="bibr">Oprea 2004</xref>). When interpreting these values it has to be considered that the hit rates are highly dependent on the target and the quality of the pharmacophore models, which again are closely related to the available structural information used as starting point for model generation.</p>
      <p>On average the virtual prediction of Prasaplai components was satisfactory. Although 0% of the VH of <italic>Acorus calamus</italic> was predicted correctly (none of the three VH was considered to be active), rates of correct prediction of 40, 50 and even 80% could be achieved by the VH of <italic>Nigella sativa</italic>, <italic>Piper nigrum</italic>, and <italic>Zingiber cassumunar</italic>, respectively. The highest rate was obtained by the VH of <italic>Zingiber officinale</italic> (100%). The resulting average rate of correct prediction of 56% is comparable to published virtual prediction values in the field of pharmaceutical chemistry (<xref rid="bib0035" ref-type="bibr">Doman et al. 2002</xref>).</p>
      <p>The evaluation of the performed computational approach underlying this study is influenced by different factors. In many cases negative results from biological testing are not published. We suggest that this is the reason we found only a small number of inactive substances in literature (23 vs. 23 actives). Another problem represents the reliability of literature data. Even if the data are correct, the authors of the publications used different test systems, which results in the problem that inhibition values cannot be directly compared. Even literature data regarding one compound are often inconsistent.</p>
      <p>In general, one reason for not finding actives might be the fact that a pharmacophore model only represents one binding mode. Consequently, the inhibitory activity of a compound might be due to another binding mode which is not covered by the pharmacophore model set.</p>
      <p>However, by the application of the Prasaplai components to PS with a set of COX pharmacophore models, molecular compounds were identified that are at least in part responsible for the COX-inhibitory activity of the Thai mixture. Furthermore, the results of the pharmacophore models validation with Prasaplai components confirm that – in comparison to a random screening approach – the virtual approach is able to increase the chance to find actives.</p>
    </sec>
    <sec id="sec0105">
      <title>Conclusion</title>
      <p>Computational approaches are effective strategies in drug discovery. They have the potential to decrease cost and time of drug development. In this study, the applicability and efficiency of pharmacophore-based PS was shown when searching for bioactive NPs. In this application scenario, active compounds were successfully identified from a structurally diverse mixture. In total, 57% of the compounds in the validation set were predicted correctly by the COX pharmacophore models. Thus, the pharmacophore-based virtual PS revealed as a powerful tool to identify COX inhibitors from a complex mixture of NPs. We suggest that this approach can be applied to several kinds of plants and plant mixtures and is not limited to COX enzymes but can also be used for other targets.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="bib0005">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ali</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Mechanism by which garlic (Allium sativum) inhibits cyclooxygenase activity. Effect of raw versus boiled garlic extract on the synthesis of prostanoids</article-title>
          <source>Prostaglandins Leukot. Essent. Fatty Acids</source>
          <volume>53</volume>
          <year>1995</year>
          <fpage>397</fpage>
          <lpage>400</lpage>
          <pub-id pub-id-type="pmid">8821119</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0010">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ali</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Angelo-Khattar</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Farid</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Hassan</surname>
              <given-names>R.A.</given-names>
            </name>
            <name>
              <surname>Thulesius</surname>
              <given-names>O.</given-names>
            </name>
          </person-group>
          <article-title>Aqueous extracts of garlic (Allium sativum) inhibit prostaglandin synthesis in the ovine ureter</article-title>
          <source>Prostaglandins Leukot. Essent. Fatty Acids</source>
          <volume>49</volume>
          <year>1993</year>
          <fpage>855</fpage>
          <lpage>859</lpage>
          <pub-id pub-id-type="pmid">8302920</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0015">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Berman</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Henrick</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Nakamura</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Announcing the worldwide Protein Data Bank</article-title>
          <source>Nat. Struct. Biol.</source>
          <volume>10</volume>
          <year>2003</year>
          <fpage>980</fpage>
          <pub-id pub-id-type="pmid">14634627</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0020">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carcache-Blanco</surname>
              <given-names>E.J.</given-names>
            </name>
            <name>
              <surname>Cuendet</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>E.J.</given-names>
            </name>
            <name>
              <surname>Su</surname>
              <given-names>B.N.</given-names>
            </name>
            <name>
              <surname>Rivero-Cruz</surname>
              <given-names>J.F.</given-names>
            </name>
            <name>
              <surname>Farnsworth</surname>
              <given-names>N.R.</given-names>
            </name>
            <name>
              <surname>Pezzuto</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Douglas Kinghorn</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Potential cancer chemopreventive agents from Arbutus unedo</article-title>
          <source>Nat. Prod. Res.</source>
          <volume>20</volume>
          <year>2006</year>
          <fpage>327</fpage>
          <lpage>334</lpage>
          <pub-id pub-id-type="pmid">16644527</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0025">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Connolly</surname>
              <given-names>T.P.</given-names>
            </name>
          </person-group>
          <article-title>Cyclooxygenase-2 inhibitors in gynecologic practice</article-title>
          <source>Clin. Med. Res.</source>
          <volume>1</volume>
          <year>2003</year>
          <fpage>105</fpage>
          <lpage>110</lpage>
          <pub-id pub-id-type="pmid">15931296</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0030">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dewhirst</surname>
              <given-names>F.E.</given-names>
            </name>
          </person-group>
          <article-title>Structure–activity relationships for inhibition of prostaglandin cyclooxygenase by phenolic compounds</article-title>
          <source>Prostaglandins</source>
          <volume>20</volume>
          <year>1980</year>
          <fpage>209</fpage>
          <lpage>222</lpage>
          <pub-id pub-id-type="pmid">6774382</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0035">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Doman</surname>
              <given-names>T.N.</given-names>
            </name>
            <name>
              <surname>McGovern</surname>
              <given-names>S.L.</given-names>
            </name>
            <name>
              <surname>Witherbee</surname>
              <given-names>B.J.</given-names>
            </name>
            <name>
              <surname>Kasten</surname>
              <given-names>T.P.</given-names>
            </name>
            <name>
              <surname>Kurumbail</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Stallings</surname>
              <given-names>W.C.</given-names>
            </name>
            <name>
              <surname>Connolly</surname>
              <given-names>D.T.</given-names>
            </name>
            <name>
              <surname>Shoichet</surname>
              <given-names>B.K.</given-names>
            </name>
          </person-group>
          <article-title>Molecular docking and high-throughput screening for novel inhibitors of protein tyrosine phosphatase-1B</article-title>
          <source>J. Med. Chem.</source>
          <volume>45</volume>
          <year>2002</year>
          <fpage>2213</fpage>
          <lpage>2221</lpage>
          <pub-id pub-id-type="pmid">12014959</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0040">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ekins</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Mestres</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Testa</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>In silico pharmacology for drug discovery: applications to targets and beyond</article-title>
          <source>Br. J. Pharmacol.</source>
          <volume>152</volume>
          <year>2007</year>
          <fpage>21</fpage>
          <lpage>37</lpage>
          <pub-id pub-id-type="pmid">17549046</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0045">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ekins</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Mestres</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Testa</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling</article-title>
          <source>Br. J. Pharmacol.</source>
          <volume>152</volume>
          <year>2007</year>
          <fpage>9</fpage>
          <lpage>20</lpage>
          <pub-id pub-id-type="pmid">17549047</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0050">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fiebich</surname>
              <given-names>B.L.</given-names>
            </name>
            <name>
              <surname>Lieb</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Kammerer</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Hull</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Synergistic inhibitory effect of ascorbic acid and acetylsalicylic acid on prostaglandin E2 release in primary rat microglia</article-title>
          <source>J. Neurochem.</source>
          <volume>86</volume>
          <year>2003</year>
          <fpage>173</fpage>
          <lpage>178</lpage>
          <pub-id pub-id-type="pmid">12807437</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0055">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gafner</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>S.K.</given-names>
            </name>
            <name>
              <surname>Cuendet</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Barthelemy</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Vergnes</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Labidalle</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Mehta</surname>
              <given-names>R.G.</given-names>
            </name>
            <name>
              <surname>Boone</surname>
              <given-names>C.W.</given-names>
            </name>
            <name>
              <surname>Pezzuto</surname>
              <given-names>J.M.</given-names>
            </name>
          </person-group>
          <article-title>Biologic evaluation of curcumin and structural derivatives in cancer chemoprevention model systems</article-title>
          <source>Phytochemistry</source>
          <volume>65</volume>
          <year>2004</year>
          <fpage>2849</fpage>
          <lpage>2859</lpage>
          <pub-id pub-id-type="pmid">15501252</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0060">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gerhaeuser</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Alt</surname>
              <given-names>A.P.</given-names>
            </name>
            <name>
              <surname>Klimo</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Knauft</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Frank</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Becker</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Isolation and potential cancer chemopreventive activities of phenolic compounds of beer</article-title>
          <source>Phytochem. Rev.</source>
          <volume>1</volume>
          <year>2003</year>
          <fpage>369</fpage>
          <lpage>377</lpage>
        </element-citation>
      </ref>
      <ref id="bib0065">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gerhaeuser</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Klimo</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Heiss</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Neumann</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Gamal-Eldeen</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Knauft</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>G.Y.</given-names>
            </name>
            <name>
              <surname>Sitthimonchai</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Frank</surname>
              <given-names>N.</given-names>
            </name>
          </person-group>
          <article-title>Mechanism-based in vitro screening of potential cancer chemopreventive agents</article-title>
          <source>Mutat. Res.</source>
          <volume>523-524</volume>
          <year>2003</year>
          <fpage>163</fpage>
          <lpage>172</lpage>
          <pub-id pub-id-type="pmid">12628514</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0070">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gupta</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Selinsky</surname>
              <given-names>B.S.</given-names>
            </name>
            <name>
              <surname>Loll</surname>
              <given-names>P.J.</given-names>
            </name>
          </person-group>
          <article-title>2.0 angstroms structure of prostaglandin H2 synthase-1 reconstituted with a manganese porphyrin cofactor</article-title>
          <source>Acta Crystallogr., Sect. D: Biol. Crystallogr. D</source>
          <volume>62</volume>
          <year>2006</year>
          <fpage>151</fpage>
          <lpage>156</lpage>
        </element-citation>
      </ref>
      <ref id="bib0075">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Han</surname>
              <given-names>A.R.</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>M.S.</given-names>
            </name>
            <name>
              <surname>Jeong</surname>
              <given-names>Y.H.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>S.K.</given-names>
            </name>
            <name>
              <surname>Seo</surname>
              <given-names>E.K.</given-names>
            </name>
          </person-group>
          <article-title>Cyclooxygenase-2 inhibitory phenylbutenoids from the rhizomes of Zingiber cassumunar</article-title>
          <source>Chem. Pharm. Bull.</source>
          <volume>53</volume>
          <year>2005</year>
          <fpage>1466</fpage>
          <lpage>1468</lpage>
          <pub-id pub-id-type="pmid">16272734</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0080">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Handler</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Jaeger</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Puschacher</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Leisser</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Erker</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis of novel curcumin analogues and their evaluation as selective cyclooxygenase-1 (COX-1) inhibitors</article-title>
          <source>Chem. Pharm. Bull.</source>
          <volume>55</volume>
          <year>2007</year>
          <fpage>64</fpage>
          <lpage>71</lpage>
          <pub-id pub-id-type="pmid">17202703</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0085">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hayes</surname>
              <given-names>E.C.</given-names>
            </name>
            <name>
              <surname>Rock</surname>
              <given-names>J.A.</given-names>
            </name>
          </person-group>
          <article-title>COX-2 inhibitors and their role in gynecology</article-title>
          <source>Obstet. Gynecol. Surv.</source>
          <volume>57</volume>
          <year>2002</year>
          <fpage>768</fpage>
          <lpage>780</lpage>
          <pub-id pub-id-type="pmid">12447099</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0090">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Henry</surname>
              <given-names>G.E.</given-names>
            </name>
            <name>
              <surname>Momin</surname>
              <given-names>R.A.</given-names>
            </name>
            <name>
              <surname>Nair</surname>
              <given-names>M.G.</given-names>
            </name>
            <name>
              <surname>Dewitt</surname>
              <given-names>D.L.</given-names>
            </name>
          </person-group>
          <article-title>Antioxidant and cyclooxygenase activities of fatty acids found in food</article-title>
          <source>J. Agric. Food Chem.</source>
          <volume>50</volume>
          <year>2002</year>
          <fpage>2231</fpage>
          <lpage>2234</lpage>
          <pub-id pub-id-type="pmid">11929276</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0095">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Huss</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Ringbom</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Perera</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Bohlin</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Vasange</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Screening of ubiquitous plant constituents for COX-2 inhibition with a scintillation proximity based assay</article-title>
          <source>J. Nat. Prod.</source>
          <volume>65</volume>
          <year>2002</year>
          <fpage>1517</fpage>
          <lpage>1521</lpage>
          <pub-id pub-id-type="pmid">12444669</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0100">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jager</surname>
              <given-names>A.K.</given-names>
            </name>
            <name>
              <surname>Petersen</surname>
              <given-names>K.N.</given-names>
            </name>
            <name>
              <surname>Thomasen</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Christensen</surname>
              <given-names>S.B.</given-names>
            </name>
          </person-group>
          <article-title>Isolation of linoleic and alpha-linolenic acids as COX-1 and -2 inhibitors in rose hip</article-title>
          <source>Phytother. Res.</source>
          <volume>22</volume>
          <year>2008</year>
          <fpage>982</fpage>
          <lpage>984</lpage>
          <pub-id pub-id-type="pmid">18389471</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0105">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jayaprakasam</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Alexander-Lindo</surname>
              <given-names>R.L.</given-names>
            </name>
            <name>
              <surname>DeWitt</surname>
              <given-names>D.L.</given-names>
            </name>
            <name>
              <surname>Nair</surname>
              <given-names>M.G.</given-names>
            </name>
          </person-group>
          <article-title>Terpenoids from Stinking toe (Hymneae courbaril) fruits with cyclooxygenase and lipid peroxidation inhibitory activities</article-title>
          <source>Food Chem.</source>
          <volume>105</volume>
          <year>2007</year>
          <fpage>485</fpage>
          <lpage>490</lpage>
        </element-citation>
      </ref>
      <ref id="bib0110">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kirchmair</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Distinto</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Schuster</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Spitzer</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Langer</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Wolber</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Enhancing drug discovery through in silico screening: strategies to increase true positives retrieval rates</article-title>
          <source>Curr. Med. Chem.</source>
          <volume>15</volume>
          <year>2008</year>
          <fpage>2040</fpage>
          <lpage>2053</lpage>
          <pub-id pub-id-type="pmid">18691055</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0115">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kurumbail</surname>
              <given-names>R.G.</given-names>
            </name>
            <name>
              <surname>Stevens</surname>
              <given-names>A.M.</given-names>
            </name>
            <name>
              <surname>Gierse</surname>
              <given-names>J.K.</given-names>
            </name>
            <name>
              <surname>McDonald</surname>
              <given-names>J.J.</given-names>
            </name>
            <name>
              <surname>Stegeman</surname>
              <given-names>R.A.</given-names>
            </name>
            <name>
              <surname>Pak</surname>
              <given-names>J.Y.</given-names>
            </name>
            <name>
              <surname>Gildehaus</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Miyashiro</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Penning</surname>
              <given-names>T.D.</given-names>
            </name>
            <name>
              <surname>Seibert</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Isakson</surname>
              <given-names>P.C.</given-names>
            </name>
            <name>
              <surname>Stallings</surname>
              <given-names>W.C.</given-names>
            </name>
          </person-group>
          <article-title>Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents</article-title>
          <source>Nature</source>
          <volume>384</volume>
          <year>1996</year>
          <fpage>644</fpage>
          <lpage>648</lpage>
          <pub-id pub-id-type="pmid">8967954</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0120">
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Langer</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Hoffmann</surname>
              <given-names>R.D.</given-names>
            </name>
            <name>
              <surname>Mannhold</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <chapter-title>Pharmacophores and Pharmacophore Searches</chapter-title>
          <year>2006</year>
          <publisher-name>Wiley-VCH</publisher-name>
          <publisher-loc>Weinheim</publisher-loc>
        </element-citation>
      </ref>
      <ref id="bib0125">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leach</surname>
              <given-names>A.R.</given-names>
            </name>
            <name>
              <surname>Gillet</surname>
              <given-names>V.J.</given-names>
            </name>
            <name>
              <surname>Lewis</surname>
              <given-names>R.A.</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Three-dimensional pharmacophore methods in drug discovery</article-title>
          <source>J. Med. Chem</source>
          <volume>53</volume>
          <year>2010</year>
          <fpage>539</fpage>
          <lpage>558</lpage>
          <pub-id pub-id-type="pmid">19831387</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0130">
        <mixed-citation publication-type="other">List of Herbal Medicinal Products A.D. 2006. Chuoomnoom Sahakorn Karnkaset Publisher, Bangkok</mixed-citation>
      </ref>
      <ref id="bib0135">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Loll</surname>
              <given-names>P.J.</given-names>
            </name>
            <name>
              <surname>Picot</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Ekabo</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Garavito</surname>
              <given-names>R.M.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and use of iodinated nonsteroidal antiinflammatory drug analogs as crystallographic probes of the prostaglandin H2 synthase cyclooxygenase active site</article-title>
          <source>Biochemistry</source>
          <volume>35</volume>
          <year>1996</year>
          <fpage>7330</fpage>
          <lpage>7340</lpage>
          <pub-id pub-id-type="pmid">8652509</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0140">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marsik</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Kokoska</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Landa</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Nepovim</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Soudek</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Vanek</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>In vitro inhibitory effects of thymol and quinones of Nigella sativa seeds on cyclooxygenase-1- and -2-catalyzed prostaglandin E2 biosyntheses</article-title>
          <source>Planta Med.</source>
          <volume>71</volume>
          <year>2005</year>
          <fpage>739</fpage>
          <lpage>742</lpage>
          <pub-id pub-id-type="pmid">16142638</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0145">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Momin</surname>
              <given-names>R.A.</given-names>
            </name>
            <name>
              <surname>De Witt</surname>
              <given-names>D.L.</given-names>
            </name>
            <name>
              <surname>Nair</surname>
              <given-names>M.G.</given-names>
            </name>
          </person-group>
          <article-title>Inhibition of cyclooxygenase (COX) enzymes by compounds from Daucus carota L. seeds</article-title>
          <source>Phytother. Res.</source>
          <volume>17</volume>
          <year>2003</year>
          <fpage>976</fpage>
          <lpage>979</lpage>
          <pub-id pub-id-type="pmid">13680840</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0150">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Muller-Jakic</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Breu</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Probstle</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Redl</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Greger</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Bauer</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>In vitro inhibition of cyclooxygenase and 5-lipoxygenase by alkamides from Echinacea and Achillea species</article-title>
          <source>Planta Med.</source>
          <volume>60</volume>
          <year>1994</year>
          <fpage>37</fpage>
          <lpage>40</lpage>
          <pub-id pub-id-type="pmid">8134414</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0155">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nualkaew</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Gritsanapan</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Petereit</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Nahrstedt</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>New fatty acid esters originate during storage by the interaction of components in prasaplai, a Thai traditional medicine</article-title>
          <source>Planta Med.</source>
          <volume>70</volume>
          <year>2004</year>
          <fpage>1243</fpage>
          <lpage>1246</lpage>
          <pub-id pub-id-type="pmid">15643567</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0160">
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Nualkaew</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Tiangda</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Gritsanapan</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Bauer</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Nahrstedt</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <chapter-title>Confirmation of biological activities of Prasaplai, a Thai traditional medicine</chapter-title>
          <source>Book of Abstracts, 53rd Annual Congress of the Society for Medicinal Plant Research, P492</source>
          <year>2005</year>
          <fpage>359</fpage>
        </element-citation>
      </ref>
      <ref id="bib0165">
        <mixed-citation publication-type="other">Oprea, T., 2004. Euro QSAR Istanbul, Istanbul.</mixed-citation>
      </ref>
      <ref id="bib0170">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Peana</surname>
              <given-names>A.T.</given-names>
            </name>
            <name>
              <surname>Marzocco</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Popolo</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Pinto</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>(−)-Linalool inhibits in vitro NO formation: probable involvement in the antinociceptive activity of this monoterpene compound</article-title>
          <source>Life Sci.</source>
          <volume>78</volume>
          <year>2006</year>
          <fpage>719</fpage>
          <lpage>723</lpage>
          <pub-id pub-id-type="pmid">16137709</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0175">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Picot</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Loll</surname>
              <given-names>P.J.</given-names>
            </name>
            <name>
              <surname>Garavito</surname>
              <given-names>R.M.</given-names>
            </name>
          </person-group>
          <article-title>The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1</article-title>
          <source>Nature</source>
          <volume>367</volume>
          <year>1994</year>
          <fpage>243</fpage>
          <lpage>249</lpage>
          <pub-id pub-id-type="pmid">8121489</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0180">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rollinger</surname>
              <given-names>J.M.</given-names>
            </name>
          </person-group>
          <article-title>Accessing target information by virtual parallel screening—the impact on natural product research</article-title>
          <source>Phytochem. Lett.</source>
          <volume>2</volume>
          <year>2009</year>
          <fpage>53</fpage>
          <lpage>58</lpage>
        </element-citation>
      </ref>
      <ref id="bib0185">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rollinger</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Bodensieck</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Seger</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Ellmerer</surname>
              <given-names>E.P.</given-names>
            </name>
            <name>
              <surname>Bauer</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Langer</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Stuppner</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Discovering COX-inhibiting constituents of Morus root bark: activity-guided versus computer-aided methods</article-title>
          <source>Planta Med.</source>
          <volume>71</volume>
          <year>2005</year>
          <fpage>399</fpage>
          <lpage>405</lpage>
          <pub-id pub-id-type="pmid">15931575</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0190">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rollinger</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Hornick</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Langer</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Stuppner</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Prast</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Acetylcholinesterase inhibitory activity of scopolin and scopoletin discovered by virtual screening of natural products</article-title>
          <source>J. Med. Chem.</source>
          <volume>47</volume>
          <year>2004</year>
          <fpage>6248</fpage>
          <lpage>6254</lpage>
          <pub-id pub-id-type="pmid">15566295</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0195">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rollinger</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Langer</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Stuppner</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Strategies for efficient lead structure discovery from natural products</article-title>
          <source>Curr. Med. Chem.</source>
          <volume>13</volume>
          <year>2006</year>
          <fpage>1491</fpage>
          <lpage>1507</lpage>
          <pub-id pub-id-type="pmid">16787200</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0200">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rollinger</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Schuster</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Danzl</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Schwaiger</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Markt</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Schmidtke</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Gertsch</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Raduner</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Wolber</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Langer</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Stuppner</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>In silico target fishing for rationalized ligand discovery exemplified on constituents of Ruta graveolens</article-title>
          <source>Planta Med.</source>
          <volume>75</volume>
          <year>2009</year>
          <fpage>195</fpage>
          <lpage>204</lpage>
          <pub-id pub-id-type="pmid">19096995</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0205">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rollinger</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Stuppner</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Langer</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Virtual screening for the discovery of bioactive natural products</article-title>
          <source>Prog. Drug Res.</source>
          <volume>65</volume>
          <issue>211</issue>
          <year>2008</year>
          <fpage>213</fpage>
          <lpage>249</lpage>
        </element-citation>
      </ref>
      <ref id="bib0210">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sakuma</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Fujimoto</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Tagano</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Tsunomori</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Nishida</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Fujita</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Effects of nonanal, trans-2-nonenal and 4-hydroxy-2,3-trans-nonenal on cyclooxygenase and 12-lipoxygenase metabolism of arachidonic acid in rabbit platelets</article-title>
          <source>J. Pharm. Pharmacol.</source>
          <volume>49</volume>
          <year>1997</year>
          <fpage>150</fpage>
          <lpage>153</lpage>
          <pub-id pub-id-type="pmid">9055186</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0215">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schuster</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Waltenberger</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Kirchmair</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Distinto</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Markt</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Stuppner</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Rollinger</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Wolber</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Predicting cyclooxygenase inhibition by three-dimensional pharmacophoric profiling. Part I: model generation, validation and applicability in ethnopharmacology</article-title>
          <source>Mol. Inf.</source>
          <volume>29</volume>
          <year>2010</year>
          <fpage>75</fpage>
          <lpage>86</lpage>
        </element-citation>
      </ref>
      <ref id="bib0220">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schuster</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Wolber</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Identification of bioactive natural products by pharmacophore-based virtual screening</article-title>
          <source>Curr. Pharm. Des.</source>
          <volume>16</volume>
          <year>2010</year>
          <fpage>1666</fpage>
          <lpage>1681</lpage>
          <pub-id pub-id-type="pmid">20222852</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0225">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sendl</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Elbl</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Steinke</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Redl</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Breu</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Wagner</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Comparative pharmacological investigations of Allium ursinum and Allium sativum</article-title>
          <source>Planta Med.</source>
          <volume>58</volume>
          <year>1992</year>
          <fpage>1</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">1620734</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0280">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Steinhour</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Sherwani</surname>
              <given-names>S.I.</given-names>
            </name>
            <name>
              <surname>Mazerik</surname>
              <given-names>J.N.</given-names>
            </name>
            <name>
              <surname>Ciapala</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>O’Connor Butler</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Cruff</surname>
              <given-names>J.P.</given-names>
            </name>
            <name>
              <surname>Magalang</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Parthasarathy</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Sen</surname>
              <given-names>C.K.</given-names>
            </name>
            <name>
              <surname>Marsh</surname>
              <given-names>C.B.</given-names>
            </name>
            <name>
              <surname>Kuppusamy</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Parinandi</surname>
              <given-names>N.L.</given-names>
            </name>
          </person-group>
          <article-title>Redox-active antioxidant modulation of lipid signaling in vascular endothelial cells: vitamin C induces activation of phospholipase D through phospholipase A2, lipoxygenase, and cyclooxygenase</article-title>
          <source>Mol. Cell Biochem.</source>
          <volume>315</volume>
          <year>2008</year>
          <fpage>97</fpage>
          <lpage>112</lpage>
          <pub-id pub-id-type="pmid">18496733</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0230">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stohr</surname>
              <given-names>J.R.</given-names>
            </name>
            <name>
              <surname>Xiao</surname>
              <given-names>P.G.</given-names>
            </name>
            <name>
              <surname>Bauer</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Isobutylamides and a new methylbutylamide from Piper sarmentosum</article-title>
          <source>Planta Med.</source>
          <volume>65</volume>
          <year>1999</year>
          <fpage>175</fpage>
          <lpage>177</lpage>
          <pub-id pub-id-type="pmid">17260253</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0235">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Su</surname>
              <given-names>B.N.</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>L.C.</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>E.J.</given-names>
            </name>
            <name>
              <surname>Cuendet</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Santarsiero</surname>
              <given-names>B.D.</given-names>
            </name>
            <name>
              <surname>Mesecar</surname>
              <given-names>A.D.</given-names>
            </name>
            <name>
              <surname>Mehta</surname>
              <given-names>R.G.</given-names>
            </name>
            <name>
              <surname>Fong</surname>
              <given-names>H.H.</given-names>
            </name>
            <name>
              <surname>Pezzuto</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Kinghorn</surname>
              <given-names>A.D.</given-names>
            </name>
          </person-group>
          <article-title>Bioactive constituents of the seeds of Brucea javanica</article-title>
          <source>Planta Med.</source>
          <volume>68</volume>
          <year>2002</year>
          <fpage>730</fpage>
          <lpage>733</lpage>
          <pub-id pub-id-type="pmid">12221597</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0240">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Su</surname>
              <given-names>B.N.</given-names>
            </name>
            <name>
              <surname>Cuendet</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Farnsworth</surname>
              <given-names>N.R.</given-names>
            </name>
            <name>
              <surname>Fong</surname>
              <given-names>H.H.</given-names>
            </name>
            <name>
              <surname>Pezzuto</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Kinghorn</surname>
              <given-names>A.D.</given-names>
            </name>
          </person-group>
          <article-title>Activity-guided fractionation of the seeds of Ziziphus jujuba using a cyclooxygenase-2 inhibitory assay</article-title>
          <source>Planta Med.</source>
          <volume>68</volume>
          <year>2002</year>
          <fpage>1125</fpage>
          <lpage>1128</lpage>
          <pub-id pub-id-type="pmid">12494342</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0245">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Surh</surname>
              <given-names>Y.J.</given-names>
            </name>
            <name>
              <surname>Kundu</surname>
              <given-names>J.K.</given-names>
            </name>
          </person-group>
          <article-title>Cancer preventive phytochemicals as speed breakers in inflammatory signaling involved in aberrant COX-2 expression</article-title>
          <source>Curr. Cancer Drug Targets</source>
          <volume>7</volume>
          <year>2007</year>
          <fpage>447</fpage>
          <lpage>458</lpage>
          <pub-id pub-id-type="pmid">17691904</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0250">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tjendraputra</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Tran</surname>
              <given-names>V.H.</given-names>
            </name>
            <name>
              <surname>Liu-Brennan</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Roufogalis</surname>
              <given-names>B.D.</given-names>
            </name>
            <name>
              <surname>Duke</surname>
              <given-names>C.C.</given-names>
            </name>
          </person-group>
          <article-title>Effect of ginger constituents and synthetic analogues on cyclooxygenase-2 enzyme in intact cells</article-title>
          <source>Bioorg. Chem.</source>
          <volume>29</volume>
          <year>2001</year>
          <fpage>156</fpage>
          <lpage>163</lpage>
          <pub-id pub-id-type="pmid">11437391</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0255">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tohda</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Nakayama</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Hatanaka</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Komatsu</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Comparison of anti-inflammatory activities of six curcuma rhizomes: a possible curcuminoid-independent pathway mediated by Curcuma phaeocaulis extract</article-title>
          <source>Evid. Based Complement. Alternat. Med.</source>
          <volume>3</volume>
          <year>2006</year>
          <fpage>255</fpage>
          <lpage>260</lpage>
          <pub-id pub-id-type="pmid">16786056</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0260">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wagner</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Wierer</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Bauer</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Antiinflammatory drugs. Part 3. In vitro inhibition of prostaglandin biosynthesis by essential oils and phenolic compounds</article-title>
          <source>Planta Med.</source>
          <year>1986</year>
          <fpage>184</fpage>
          <lpage>187</lpage>
          <pub-id pub-id-type="pmid">3749341</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0265">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wermuth</surname>
              <given-names>C.-G.</given-names>
            </name>
            <name>
              <surname>Ganellin</surname>
              <given-names>C.R.</given-names>
            </name>
            <name>
              <surname>Lindberg</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Mitscher</surname>
              <given-names>L.A.</given-names>
            </name>
          </person-group>
          <article-title>Glossary of terms used in medicinal chemistry (IUPAC recommendations 1997)</article-title>
          <source>Annu. Rep. Med. Chem.</source>
          <volume>33</volume>
          <year>1998</year>
          <fpage>385</fpage>
          <lpage>395</lpage>
        </element-citation>
      </ref>
      <ref id="bib0270">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yano</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Suzuki</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Yuzurihara</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kase</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Takeda</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Watanabe</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Aburada</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Miyamoto</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Antinociceptive effect of methyleugenol on formalin-induced hyperalgesia in mice</article-title>
          <source>Eur. J. Pharmacol.</source>
          <volume>553</volume>
          <year>2006</year>
          <fpage>99</fpage>
          <lpage>103</lpage>
          <pub-id pub-id-type="pmid">17049512</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0275">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Jayaprakasam</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Seeram</surname>
              <given-names>N.P.</given-names>
            </name>
            <name>
              <surname>Olson</surname>
              <given-names>L.K.</given-names>
            </name>
            <name>
              <surname>DeWitt</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Nair</surname>
              <given-names>M.G.</given-names>
            </name>
          </person-group>
          <article-title>Insulin secretion and cyclooxygenase enzyme inhibition by cabernet sauvignon grape skin compounds</article-title>
          <source>J. Agric. Food Chem.</source>
          <volume>52</volume>
          <year>2004</year>
          <fpage>228</fpage>
          <lpage>233</lpage>
          <pub-id pub-id-type="pmid">14733500</pub-id>
        </element-citation>
      </ref>
    </ref-list>
    <ack>
      <title>Acknowledgment</title>
      <p>This work was supported by the National Research Network – project “DNTI” S10703-B03 granted by the Austrian Science Fund (FWF), by a Young Talents Grant (Nachwuchsförderung) by the University of Innsbruck to D.S., and by the Thailand Research Fund (The Royal Golden Jubilee Ph.D. Program, grant PHD/0202/2547).</p>
    </ack>
  </back>
  <floats-group>
    <fig id="fig0005">
      <label>Fig. 1</label>
      <caption>
        <p>Number of VH obtained from PS (grey columns) vs. number of known components of the plants Prasaplai is composed of (white columns).</p>
      </caption>
      <graphic xlink:href="gr1"/>
    </fig>
    <fig id="fig0010">
      <label>Fig. 2</label>
      <caption>
        <p>Decision tree for validation of pharmacophore model set.</p>
      </caption>
      <graphic xlink:href="gr2"/>
    </fig>
    <fig id="fig0015">
      <label>Fig. 3</label>
      <caption>
        <p>General workflow of the virtual PS approach performed in this study.</p>
      </caption>
      <graphic xlink:href="gr3"/>
    </fig>
    <fig id="fig0020">
      <label>Fig. 4</label>
      <caption>
        <p>Numbers of VH included in pharmacophore models validation. Threshold: highly active, IC<sub>50</sub> &lt; 25.0 μM (dark grey); moderately active, IC<sub>50</sub> = 25.0–150.0 μM (light grey); inactive, IC<sub>50</sub> &gt; 150.0 μM (white).</p>
      </caption>
      <graphic xlink:href="gr4"/>
    </fig>
    <fig id="fig0025">
      <label>Fig. 5</label>
      <caption>
        <p>Numbers of non-VH included in pharmacophore models validation. Threshold: highly active, IC<sub>50</sub> &lt; 25.0 μM (dark grey); moderately active, IC<sub>50</sub> = 25.0–150.0 μM (light grey); inactive, IC<sub>50</sub> &gt; 150.0 μM (white).</p>
      </caption>
      <graphic xlink:href="gr5"/>
    </fig>
    <table-wrap id="tbl0005" position="float">
      <label>Table 1</label>
      <caption>
        <p>COX Inhibitor Pharmacophore Models used for PS of Prasaplai Components.</p>
      </caption>
      <table frame="hsides" rules="groups">
        <tbody>
          <tr>
            <td align="left">3D chart<xref rid="tblfn0005" ref-type="table-fn">a</xref></td>
            <td align="left">
              <inline-graphic xlink:href="fx1.gif"/>
            </td>
            <td align="left">
              <inline-graphic xlink:href="fx2.gif"/>
            </td>
            <td align="left">
              <inline-graphic xlink:href="fx3.gif"/>
            </td>
          </tr>
          <tr>
            <td align="left">Name</td>
            <td align="left">1cqe-1</td>
            <td align="left">1pge-2-s</td>
            <td align="left">2ayl-1</td>
          </tr>
          <tr>
            <td align="left">PDB entry</td>
            <td align="left">1cqe (<xref rid="bib0175" ref-type="bibr">Picot et al. 1994</xref>)</td>
            <td align="left">1pge (<xref rid="bib0135" ref-type="bibr">Loll et al. 1996</xref>)</td>
            <td align="left">2ayl (<xref rid="bib0070" ref-type="bibr">Gupta et al. 2006</xref>)</td>
          </tr>
          <tr>
            <td align="left">Complex</td>
            <td align="left">COX-1/flurbiprofen</td>
            <td align="left">COX-1/iodosuprofen</td>
            <td align="left">COX-1/flurbiprofen</td>
          </tr>
          <tr>
            <td colspan="4" align="left">  </td>
          </tr>
          <tr>
            <td align="left">3D chart<xref rid="tblfn0005" ref-type="table-fn">a</xref></td>
            <td align="left">
              <inline-graphic xlink:href="fx4.gif"/>
            </td>
            <td align="left">
              <inline-graphic xlink:href="fx5.gif"/>
            </td>
            <td align="left">
              <inline-graphic xlink:href="fx6.gif"/>
            </td>
          </tr>
          <tr>
            <td align="left">Name</td>
            <td align="left">4cox-2</td>
            <td align="left">6cox-1-s</td>
            <td align="left">Ligand-based model</td>
          </tr>
          <tr>
            <td align="left">PDB entry</td>
            <td align="left">4cox (<xref rid="bib0115" ref-type="bibr">Kurumbail et al. 1996</xref>)</td>
            <td align="left">6cox (<xref rid="bib0115" ref-type="bibr">Kurumbail et al. 1996</xref>)</td>
            <td align="left">–</td>
          </tr>
          <tr>
            <td align="left">Complex</td>
            <td align="left">COX-2/indometacin</td>
            <td align="left">COX-2/S-558</td>
            <td align="left">–</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn id="tblfn0005">
          <label>a</label>
          <p>3D chart of pharmacophore model with underlying COX ligand(s). Exclusion volumes are omitted for better transparency. Instead, the surface of the binding pocket is depicted to show the steric constraints of the model.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <table-wrap id="tbl0010" position="float" orientation="landscape">
      <?landscape?>
      <?legal?>
      <label>Table 2</label>
      <caption>
        <p>VH with published COX-inhibitory activities.</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th align="left">Compound</th>
            <th align="left">Prasaplai plant origin</th>
            <th align="left">COX-1 inhibitory activity</th>
            <th align="left">COX-2 inhibitory activity</th>
            <th align="left">Structure</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td align="left">Palmitic acid</td>
            <td align="left"><italic>Acorus calamus</italic>, <italic>Nigella sativa</italic></td>
            <td align="left">No inhibition (390 μM) (<xref rid="bib0090" ref-type="bibr">Henry et al. 2002</xref>)</td>
            <td align="left">No inhibition (390 μM) (<xref rid="bib0090" ref-type="bibr">Henry et al. 2002</xref>)</td>
            <td align="left">
              <inline-graphic xlink:href="fx7.gif"/>
            </td>
          </tr>
          <tr>
            <td align="left">Asaraldehyde</td>
            <td align="left">
              <italic>Acorus calamus</italic>
            </td>
            <td align="left">3.32% (510 μM) (<xref rid="bib0145" ref-type="bibr">Momin et al. 2003</xref>)</td>
            <td align="left">52.69% (510 μM) (<xref rid="bib0145" ref-type="bibr">Momin et al. 2003</xref>)</td>
            <td align="left">
              <inline-graphic xlink:href="fx8.gif"/>
            </td>
          </tr>
          <tr>
            <td align="left">α-Asarone</td>
            <td align="left">
              <italic>Acorus calamus</italic>
            </td>
            <td align="left">46.15% (480 μM) (<xref rid="bib0145" ref-type="bibr">Momin et al. 2003</xref>)</td>
            <td align="left">64.39% (480 μM) (<xref rid="bib0145" ref-type="bibr">Momin et al. 2003</xref>)</td>
            <td align="left">
              <inline-graphic xlink:href="fx9.gif"/>
            </td>
          </tr>
          <tr>
            <td align="left">Myristic acid</td>
            <td align="left">
              <italic>Nigella sativa</italic>
            </td>
            <td align="left">No inhibition (438 μM) (<xref rid="bib0090" ref-type="bibr">Henry et al. 2002</xref>)</td>
            <td align="left">No inhibition (438 μM) (<xref rid="bib0090" ref-type="bibr">Henry et al. 2002</xref>)</td>
            <td align="left">
              <inline-graphic xlink:href="fx10.gif"/>
            </td>
          </tr>
          <tr>
            <td align="left">Pentadecanoic acid</td>
            <td align="left">
              <italic>Nigella sativa</italic>
            </td>
            <td align="left">No inhibition (413 μM) (<xref rid="bib0090" ref-type="bibr">Henry et al. 2002</xref>)</td>
            <td align="left">No inhibition (413 μM) (<xref rid="bib0090" ref-type="bibr">Henry et al. 2002</xref>)</td>
            <td align="left">
              <inline-graphic xlink:href="fx11.gif"/>
            </td>
          </tr>
          <tr>
            <td align="left">α-Linolenic acid</td>
            <td align="left"><italic>Nigella sativa</italic>, <italic>Zingiber officinale</italic></td>
            <td align="left">∼93% (359 μM) (<xref rid="bib0090" ref-type="bibr">Henry et al. 2002</xref>), IC<sub>50</sub> = 52 μM (<xref rid="bib0100" ref-type="bibr">Jager et al. 2008</xref>)</td>
            <td align="left">∼96% (359 μM) (<xref rid="bib0090" ref-type="bibr">Henry et al. 2002</xref>), IC<sub>50</sub> = 12 μM (<xref rid="bib0100" ref-type="bibr">Jager et al. 2008</xref>)</td>
            <td align="left">
              <inline-graphic xlink:href="fx12.gif"/>
            </td>
          </tr>
          <tr>
            <td align="left">Palmitoleic acid</td>
            <td align="left">
              <italic>Nigella sativa</italic>
            </td>
            <td align="left">∼11% (393 μM) (<xref rid="bib0090" ref-type="bibr">Henry et al. 2002</xref>)</td>
            <td align="left">No inhibition (393 μM) (<xref rid="bib0090" ref-type="bibr">Henry et al. 2002</xref>)</td>
            <td align="left">
              <inline-graphic xlink:href="fx13.gif"/>
            </td>
          </tr>
          <tr>
            <td align="left">Linoleic acid</td>
            <td align="left">
              <italic>Nigella sativa</italic>
            </td>
            <td align="left">∼87% (357 μM) (<xref rid="bib0090" ref-type="bibr">Henry et al. 2002</xref>), IC<sub>50</sub> = 85 μM (<xref rid="bib0100" ref-type="bibr">Jager et al. 2008</xref>), IC<sub>50</sub> = 52.2 μM (<xref rid="bib0240" ref-type="bibr">Su et al. 2002b</xref>)</td>
            <td align="left">∼94% (357 μM) (<xref rid="bib0090" ref-type="bibr">Henry et al. 2002</xref>), IC<sub>50</sub> = 0.6 μM (<xref rid="bib0100" ref-type="bibr">Jager et al. 2008</xref>), IC<sub>50</sub> = 1.9 μM (<xref rid="bib0240" ref-type="bibr">Su et al. 2002b</xref>)</td>
            <td align="left">
              <inline-graphic xlink:href="fx14.gif"/>
            </td>
          </tr>
          <tr>
            <td align="left">Oleic acid</td>
            <td align="left">
              <italic>Nigella sativa</italic>
            </td>
            <td align="left">25% (354 μM) (<xref rid="bib0090" ref-type="bibr">Henry et al. 2002</xref>), 45.32% (354 μM) (<xref rid="bib0145" ref-type="bibr">Momin et al. 2003</xref>), IC<sub>50</sub> = 85.3 μM (<xref rid="bib0240" ref-type="bibr">Su et al. 2002b</xref>)</td>
            <td align="left">Little or no activity (354 μM) (<xref rid="bib0090" ref-type="bibr">Henry et al. 2002</xref>), 68.41% (354 μM) (<xref rid="bib0145" ref-type="bibr">Momin et al. 2003</xref>), IC<sub>50</sub> = 0.7 μM (<xref rid="bib0240" ref-type="bibr">Su et al. 2002b</xref>)</td>
            <td align="left">
              <inline-graphic xlink:href="fx15.gif"/>
            </td>
          </tr>
          <tr>
            <td align="left">Stearic acid</td>
            <td align="left">
              <italic>Nigella sativa</italic>
            </td>
            <td align="left">No inhibition (352 μM) (<xref rid="bib0090 bib0240" ref-type="bibr">Henry et al. 2002; Su et al. 2002b</xref>)</td>
            <td align="left">No inhibition (352 μM) (<xref rid="bib0090 bib0240" ref-type="bibr">Henry et al. 2002; Su et al. 2002b</xref>)</td>
            <td align="left">
              <inline-graphic xlink:href="fx16.gif"/>
            </td>
          </tr>
          <tr>
            <td align="left">Erucic acid</td>
            <td align="left">
              <italic>Nigella sativa</italic>
            </td>
            <td align="left">No inhibition (295 μM) (<xref rid="bib0090" ref-type="bibr">Henry et al. 2002</xref>)</td>
            <td align="left">No inhibition (295 μM) (<xref rid="bib0090" ref-type="bibr">Henry et al. 2002</xref>)</td>
            <td align="left">
              <inline-graphic xlink:href="fx17.gif"/>
            </td>
          </tr>
          <tr>
            <td align="left">Eugenol</td>
            <td align="left"><italic>Nigella sativa</italic>, <italic>Piper nigrum</italic></td>
            <td align="left">nd<xref rid="tblfn0010" ref-type="table-fn">a</xref></td>
            <td align="left">IC<sub>50</sub> = 129 μM (<xref rid="bib0095" ref-type="bibr">Huss et al. 2002</xref>)</td>
            <td align="left">
              <inline-graphic xlink:href="fx18.gif"/>
            </td>
          </tr>
          <tr>
            <td align="left">Nonanoic acid</td>
            <td align="left">
              <italic>Piper nigrum</italic>
            </td>
            <td align="left">29% (632 μM) (<xref rid="bib0090" ref-type="bibr">Henry et al. 2002</xref>)</td>
            <td align="left">Little or no activity (632 μM) (<xref rid="bib0090" ref-type="bibr">Henry et al. 2002</xref>)</td>
            <td align="left">
              <inline-graphic xlink:href="fx19.gif"/>
            </td>
          </tr>
          <tr>
            <td align="left">Octanoic acid</td>
            <td align="left">
              <italic>Piper nigrum</italic>
            </td>
            <td align="left">12% (693 μM) (<xref rid="bib0090" ref-type="bibr">Henry et al. 2002</xref>)</td>
            <td align="left">No inhibition (693 μM) (<xref rid="bib0090" ref-type="bibr">Henry et al. 2002</xref>)</td>
            <td align="left">
              <inline-graphic xlink:href="fx20.gif"/>
            </td>
          </tr>
          <tr>
            <td align="left">Methyleugenol</td>
            <td align="left">
              <italic>Piper nigrum</italic>
            </td>
            <td align="left">27.23% (100 μM) (<xref rid="bib0270" ref-type="bibr">Yano et al. 2006</xref>)</td>
            <td align="left">42.64% (100 μM) (<xref rid="bib0270" ref-type="bibr">Yano et al. 2006</xref>)</td>
            <td align="left">
              <inline-graphic xlink:href="fx21.gif"/>
            </td>
          </tr>
          <tr>
            <td align="left">(E)-4-(3,4-Dimethoxy-phenyl)but-3-en-1-yl acetate</td>
            <td align="left">
              <italic>Zingiber cassumunar</italic>
            </td>
            <td align="left">nd</td>
            <td align="left">IC<sub>50</sub> &gt; 50 μM (<xref rid="bib0075" ref-type="bibr">Han et al. 2005</xref>)</td>
            <td align="left">
              <inline-graphic xlink:href="fx22.gif"/>
            </td>
          </tr>
          <tr>
            <td align="left">4-(2,4,5-Trimethoxy-phenyl)but-1,3-diene</td>
            <td align="left">
              <italic>Zingiber cassumunar</italic>
            </td>
            <td align="left">nd</td>
            <td align="left">IC<sub>50</sub> = 14.97 μM (<xref rid="bib0075" ref-type="bibr">Han et al. 2005</xref>)</td>
            <td align="left">
              <inline-graphic xlink:href="fx23.gif"/>
            </td>
          </tr>
          <tr>
            <td align="left">Trans-3-(3,4-dimethoxy-phenyl)-4-[(E)-3′,4′-dimethoxy-styryl]cyclohex-1-ene</td>
            <td align="left">
              <italic>Zingiber cassumunar</italic>
            </td>
            <td align="left">nd</td>
            <td align="left">IC<sub>50</sub> = 2.71 μM (<xref rid="bib0075" ref-type="bibr">Han et al. 2005</xref>)</td>
            <td align="left">
              <inline-graphic xlink:href="fx24.gif"/>
            </td>
          </tr>
          <tr>
            <td align="left">4-(3,4-Dimethoxy-phenyl) but-1,3-diene</td>
            <td align="left">
              <italic>Zingiber cassumunar</italic>
            </td>
            <td align="left">nd</td>
            <td align="left">IC<sub>50</sub> = 20.68 μM (<xref rid="bib0075" ref-type="bibr">Han et al. 2005</xref>)</td>
            <td align="left">
              <inline-graphic xlink:href="fx25.gif"/>
            </td>
          </tr>
          <tr>
            <td align="left">(±)-Trans-3-(4-hydroxy-3-methoxy-phenyl)-4-[(E)-3,4-dimethoxy-styryl]cyclo-hex-1-ene</td>
            <td align="left">
              <italic>Zingiber cassumunar</italic>
            </td>
            <td align="left">nd</td>
            <td align="left">IC<sub>50</sub> = 3.64 μM (<xref rid="bib0075" ref-type="bibr">Han et al. 2005</xref>)</td>
            <td align="left">
              <inline-graphic xlink:href="fx26.gif"/>
            </td>
          </tr>
          <tr>
            <td align="left">[6]-Shogaol</td>
            <td align="left">
              <italic>Zingiber officinale</italic>
            </td>
            <td align="left">nd</td>
            <td align="left">IC<sub>50</sub> = 2.1 μM (<xref rid="bib0250" ref-type="bibr">Tjendraputra et al. 2001</xref>)</td>
            <td align="left">
              <inline-graphic xlink:href="fx27.gif"/>
            </td>
          </tr>
          <tr>
            <td align="left">[8]-Gingerdiol</td>
            <td align="left">
              <italic>Zingiber officinale</italic>
            </td>
            <td align="left">nd</td>
            <td align="left">IC<sub>50</sub> = 12.5 μM (<xref rid="bib0250" ref-type="bibr">Tjendraputra et al. 2001</xref>)</td>
            <td align="left">
              <inline-graphic xlink:href="fx28.gif"/>
            </td>
          </tr>
          <tr>
            <td align="left">[6]-Paradol</td>
            <td align="left">
              <italic>Zingiber officinale</italic>
            </td>
            <td align="left">nd</td>
            <td align="left">IC<sub>50</sub> = 24.5 μM (<xref rid="bib0250" ref-type="bibr">Tjendraputra et al. 2001</xref>)</td>
            <td align="left">
              <inline-graphic xlink:href="fx29.gif"/>
            </td>
          </tr>
          <tr>
            <td align="left">[8]-Gingerol</td>
            <td align="left">
              <italic>Zingiber officinale</italic>
            </td>
            <td align="left">nd</td>
            <td align="left">IC<sub>50</sub> = 10.0 μM (<xref rid="bib0250" ref-type="bibr">Tjendraputra et al. 2001</xref>)</td>
            <td align="left">
              <inline-graphic xlink:href="fx30.gif"/>
            </td>
          </tr>
          <tr>
            <td align="left">[8]-Shogaol</td>
            <td align="left">
              <italic>Zingiber officinale</italic>
            </td>
            <td align="left">nd</td>
            <td align="left">IC<sub>50</sub> = 7.2 μM (<xref rid="bib0250" ref-type="bibr">Tjendraputra et al. 2001</xref>)</td>
            <td align="left">
              <inline-graphic xlink:href="fx31.gif"/>
            </td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn id="tblfn0010">
          <label>a</label>
          <p>nd, not determined.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <table-wrap id="tbl0015" position="float" orientation="landscape">
      <?landscape?>
      <?legal?>
      <label>Table 3</label>
      <caption>
        <p>Non-VH with published COX-inhibitory activities.</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th align="left">Compound</th>
            <th align="left">Prasaplai plant origin</th>
            <th align="left">COX-1 inhibitory activity</th>
            <th align="left">COX-2 inhibitory activity</th>
            <th align="left">Structure</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td align="left">Linalool</td>
            <td align="left"><italic>Acorus calamus</italic>, <italic>Nigella sativa</italic>, <italic>Piper nigrum</italic>, <italic>Zingiber officinale</italic></td>
            <td colspan="2" align="left">Significant reduction of COX-2 expression and PGE<sub>2</sub> formation only in the highest concentration (1000 μM) (<xref rid="bib0170" ref-type="bibr">Peana et al. 2006</xref>)</td>
            <td align="left">
              <inline-graphic xlink:href="fx32.gif"/>
            </td>
          </tr>
          <tr>
            <td align="left">Limonene</td>
            <td align="left"><italic>Acorus calamus</italic>, <italic>Nigella sativa</italic>, <italic>Piper nigrum</italic>, <italic>Zingiber officinale</italic>, <italic>Zingiber cassumunar</italic></td>
            <td align="left">IC<sub>50</sub> &gt; 100 μM (<xref rid="bib0065" ref-type="bibr">Gerhaeuser et al. 2003b</xref>)</td>
            <td align="left">nd<xref rid="tblfn0015" ref-type="table-fn">a</xref></td>
            <td align="left">
              <inline-graphic xlink:href="fx33.gif"/>
            </td>
          </tr>
          <tr>
            <td align="left">Thymoquinone</td>
            <td align="left">
              <italic>Nigella sativa</italic>
            </td>
            <td align="left">IC<sub>50</sub> = 2.6 μM (<xref rid="bib0140" ref-type="bibr">Marsik et al. 2005</xref>)</td>
            <td align="left">IC<sub>50</sub> = 0.3 μM (<xref rid="bib0140" ref-type="bibr">Marsik et al. 2005</xref>)</td>
            <td align="left">
              <inline-graphic xlink:href="fx34.gif"/>
            </td>
          </tr>
          <tr>
            <td align="left">Thymohydroquinone</td>
            <td align="left">
              <italic>Nigella sativa</italic>
            </td>
            <td align="left">IC<sub>50</sub> = 0.6 μM (<xref rid="bib0140" ref-type="bibr">Marsik et al. 2005</xref>)</td>
            <td align="left">IC<sub>50</sub> = 0.1 μM (<xref rid="bib0140" ref-type="bibr">Marsik et al. 2005</xref>)</td>
            <td align="left">
              <inline-graphic xlink:href="fx35.gif"/>
            </td>
          </tr>
          <tr>
            <td align="left">Dithymoquinone</td>
            <td align="left">
              <italic>Nigella sativa</italic>
            </td>
            <td align="left">IC<sub>50</sub> &gt; 100 μM (<xref rid="bib0140" ref-type="bibr">Marsik et al. 2005</xref>)</td>
            <td align="left">IC<sub>50</sub> = 0.9 μM (<xref rid="bib0140" ref-type="bibr">Marsik et al. 2005</xref>)</td>
            <td align="left">
              <inline-graphic xlink:href="fx36.gif"/>
            </td>
          </tr>
          <tr>
            <td align="left">Thymol</td>
            <td align="left">
              <italic>Nigella sativa</italic>
            </td>
            <td align="left">IC<sub>50</sub> = 0.2 μM (<xref rid="bib0140" ref-type="bibr">Marsik et al. 2005</xref>)</td>
            <td align="left">IC<sub>50</sub> = 1.0 μM (<xref rid="bib0140" ref-type="bibr">Marsik et al. 2005</xref>)</td>
            <td align="left">
              <inline-graphic xlink:href="fx37.gif"/>
            </td>
          </tr>
          <tr>
            <td align="left">Piperine</td>
            <td align="left">
              <italic>Piper nigrum</italic>
            </td>
            <td colspan="2" align="left">33.4% inhibition of PG biosynthesis at 37 μM (<xref rid="bib0260" ref-type="bibr">Wagner et al. 1986</xref>)</td>
            <td align="left">
              <inline-graphic xlink:href="fx38.gif"/>
            </td>
          </tr>
          <tr>
            <td align="left">Nonanal</td>
            <td align="left">
              <italic>Piper nigrum</italic>
            </td>
            <td colspan="2" align="left">Reduction of arachidonic acid metabolites by 50% at ∼0.25 μM (<xref rid="bib0210" ref-type="bibr">Sakuma et al. 1997</xref>)</td>
            <td align="left">
              <inline-graphic xlink:href="fx39.gif"/>
            </td>
          </tr>
          <tr>
            <td align="left">Trans-2-nonenal</td>
            <td align="left">
              <italic>Piper nigrum</italic>
            </td>
            <td colspan="2" align="left">Reduction of arachidonic acid metabolites by 50% at ∼0.25 μM (<xref rid="bib0210" ref-type="bibr">Sakuma et al. 1997</xref>)</td>
            <td align="left">
              <inline-graphic xlink:href="fx40.gif"/>
            </td>
          </tr>
          <tr>
            <td align="left">Safrole</td>
            <td align="left">
              <italic>Piper nigrum</italic>
            </td>
            <td colspan="2" align="left">IC<sub>50</sub> = 225 μM (<xref rid="bib0030" ref-type="bibr">Dewhirst 1980</xref>)</td>
            <td align="left">
              <inline-graphic xlink:href="fx41.gif"/>
            </td>
          </tr>
          <tr>
            <td align="left">Spathulenol</td>
            <td align="left">
              <italic>Piper nigrum</italic>
            </td>
            <td align="left">15% (454 μM) (<xref rid="bib0105" ref-type="bibr">Jayaprakasam et al. 2007</xref>)</td>
            <td align="left">54% (454 μM) (<xref rid="bib0105" ref-type="bibr">Jayaprakasam et al. 2007</xref>)</td>
            <td align="left">
              <inline-graphic xlink:href="fx42.gif"/>
            </td>
          </tr>
          <tr>
            <td align="left">Pellitorine</td>
            <td align="left">
              <italic>Piper nigrum</italic>
            </td>
            <td align="left">IC<sub>50</sub> &gt; 100 μM (<xref rid="bib0230" ref-type="bibr">Stohr et al. 1999</xref>)</td>
            <td/>
            <td align="left">
              <inline-graphic xlink:href="fx43.gif"/>
            </td>
          </tr>
          <tr>
            <td/>
            <td/>
            <td colspan="2" align="left">31% inhibition of COX (224 μM) (<xref rid="bib0150" ref-type="bibr">Muller-Jakic et al. 1994</xref>)</td>
            <td/>
          </tr>
          <tr>
            <td align="left">Ledol</td>
            <td align="left">
              <italic>Piper nigrum</italic>
            </td>
            <td colspan="2" align="left">No inhibition of PG biosynthesis (37 μM) (<xref rid="bib0260" ref-type="bibr">Wagner et al. 1986</xref>)</td>
            <td align="left">
              <inline-graphic xlink:href="fx44.gif"/>
            </td>
          </tr>
          <tr>
            <td align="left">(E)-4-(3,4-Dimethoxy-phenyl)but-3-en-1-ol</td>
            <td align="left">
              <italic>Zingiber cassumunar</italic>
            </td>
            <td align="left">nd</td>
            <td align="left">IC<sub>50</sub> &gt; 50 μM (<xref rid="bib0075" ref-type="bibr">Han et al. 2005</xref>)</td>
            <td align="left">
              <inline-graphic xlink:href="fx45.gif"/>
            </td>
          </tr>
          <tr>
            <td align="left">Vanillin</td>
            <td align="left">
              <italic>Zingiber cassumunar</italic>
            </td>
            <td align="left">IC<sub>50</sub> &gt; 50 μM (<xref rid="bib0235" ref-type="bibr">Su et al. 2002a</xref>)</td>
            <td align="left">IC<sub>50</sub> &gt; 50 μM (<xref rid="bib0235" ref-type="bibr">Su et al. 2002a</xref>)</td>
            <td align="left">
              <inline-graphic xlink:href="fx46.gif"/>
            </td>
          </tr>
          <tr>
            <td align="left">Vanillic acid</td>
            <td align="left">
              <italic>Zingiber cassumunar</italic>
            </td>
            <td align="left">No inhibition (100 μM) (<xref rid="bib0060" ref-type="bibr">Gerhaeuser et al. 2003a</xref>)</td>
            <td align="left">nd</td>
            <td align="left">
              <inline-graphic xlink:href="fx47.gif"/>
            </td>
          </tr>
          <tr>
            <td align="left">Curcumin</td>
            <td align="left">
              <italic>Zingiber cassumunar</italic>
            </td>
            <td align="left">IC<sub>50</sub> = 18.8 μM (<xref rid="bib0055" ref-type="bibr">Gafner et al. 2004</xref>), IC<sub>50</sub> = 50 μM (<xref rid="bib0080" ref-type="bibr">Handler et al. 2007</xref>), IC<sub>50</sub> &gt; 100 μM (<xref rid="bib0065" ref-type="bibr">Gerhaeuser et al. 2003b</xref>)</td>
            <td align="left">IC<sub>50</sub> = 15.9 μM (<xref rid="bib0055" ref-type="bibr">Gafner et al. 2004</xref>), IC<sub>50</sub> &gt; 100 μM (<xref rid="bib0080" ref-type="bibr">Handler et al. 2007</xref>)</td>
            <td align="left">
              <inline-graphic xlink:href="fx48.gif"/>
            </td>
          </tr>
          <tr>
            <td align="left">β-Sitosterol</td>
            <td align="left">
              <italic>Zingiber officinale</italic>
            </td>
            <td align="left">No inhibition (241 μM) (<xref rid="bib0275" ref-type="bibr">Zhang et al. 2004</xref>)</td>
            <td align="left">11% (241 μM) (<xref rid="bib0275" ref-type="bibr">Zhang et al. 2004</xref>), IC<sub>50</sub> &gt; 241 μM (<xref rid="bib0020" ref-type="bibr">Carcache-Blanco et al. 2006</xref>)</td>
            <td align="left">
              <inline-graphic xlink:href="fx49.gif"/>
            </td>
          </tr>
          <tr>
            <td align="left">6β-Hydroxystigmast-4-en-3-one</td>
            <td align="left">
              <italic>Zingiber officinale</italic>
            </td>
            <td align="left">nd</td>
            <td align="left">IC<sub>50</sub> &gt; 233 μM (<xref rid="bib0020" ref-type="bibr">Carcache-Blanco et al. 2006</xref>)</td>
            <td align="left">
              <inline-graphic xlink:href="fx50.gif"/>
            </td>
          </tr>
          <tr>
            <td align="left">1,8-Cineole</td>
            <td align="left">
              <italic>Zingiber officinale</italic>
            </td>
            <td colspan="2" align="left">IC<sub>50</sub> &gt; 500 μM (<xref rid="bib0030" ref-type="bibr">Dewhirst 1980</xref>)</td>
            <td align="left">
              <inline-graphic xlink:href="fx51.gif"/>
            </td>
          </tr>
          <tr>
            <td align="left">Ascorbic acid</td>
            <td align="left">
              <italic>Zingiber officinale</italic>
            </td>
            <td align="left">IC<sub>50</sub> &gt; 100 μM (<xref rid="bib0065" ref-type="bibr">Gerhaeuser et al. 2003b</xref>)</td>
            <td align="left">IC<sub>50</sub> = 3.70 μM (<xref rid="bib0050" ref-type="bibr">Fiebich et al. 2003</xref>)</td>
            <td align="left">
              <inline-graphic xlink:href="fx52.gif"/>
            </td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn id="tblfn0015">
          <label>a</label>
          <p>nd, not determined.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <table-wrap id="tbl0020" position="float">
      <label>Table 4</label>
      <caption>
        <p>Determination of correctness of virtual prediction.</p>
      </caption>
      <table frame="hsides" rules="groups">
        <tbody>
          <tr>
            <td align="left">
              <inline-graphic xlink:href="fx53.gif"/>
            </td>
          </tr>
          <tr>
            <td align="left">
              <inline-graphic xlink:href="fx54.gif"/>
            </td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn>
          <p><sup>a</sup>Threshold: active, IC<sub>50</sub> ≤ 150.0 μM; inactive, IC<sub>50</sub> &gt; 150.0 μM.</p>
          <p><sup>b</sup>Grey, correct prediction, active VH, inactive non-VH; hatched, false prediction, inactive VH, active non-VH.</p>
          <p><sup>c</sup>Correctness of prediction referring to one plant. Number of correctly predicted structures/total number of structures × 100. Example <italic>Acorus calamus</italic>: three inactive VH, two inactive non-VH; two out of five structures predicted correctly; 40% correct prediction.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
  </floats-group>
</article>